
Report ID: SQMIG35G2233
SkyQuest Technology's Bio decontamination market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global Bio Decontamination Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.
Bio Decontamination Market size was valued at USD 183.4 Billion in 2023 and is poised to grow from USD 196.24 Billion in 2024 to USD 337.17 Billion by 2032, growing at a CAGR of 7% during the forecast period (2025-2032).
According to the global bio decontamination market analysis, the main drivers propelling the market's expansion are the rise in hospital-acquired infection rates, the expansion of the biotechnology and pharmaceutical sectors, and the growing awareness and use of infection control measures. Hygiene and patient safety have become paramount issues in the world today, mainly due to hospital acquired infections having a great bearing on patient morbidity and mortality in addition to resulting in higher healthcare costs. A hospital-acquired infection (HAI) is an infection that a patient other than for treatment of that particular infection develops in a healthcare facility. Such infections are associated with red tape and complicated MDROs, hence the need for strict compliance to infection prevention and control measures. Hospitals and other healthcare facilities are therefore spending more money on cutting-edge bio decontamination systems in an effort to lower the incidence of hospital-acquired infections.
The expansion of the pharmaceutical and biotechnology sectors is anticipated to propel the growth. With the advent of biologics and personalized medicine and more advanced therapeutic modalities there has been an increased demand for improved decontamination technologies in order to maintain and protect sterile environments from microbial contamination. Moreover, the World Health Organisation, the European Medicines Agency, the United States Food and Drug Administration, and the Medicines and Healthcare Products Regulatory Agency have imposed restrictions on manufacturing processes that have forced many practices to adopt bio decontamination products. Therefore, the expanding biotechnology and pharmaceutical sectors are anticipated to propel the global bio decontamination market's expansion.
REQUEST FOR SAMPLE
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35G2233
[email protected]
USA +1 351-333-4748